TY - JOUR
T1 - Pharmacological changes in cellular Ca2+ homeostasis parallel initiation of a trial arrhythmogenesis in murine langendorff-perfused hearts
AU - Zhang, Yanmin
AU - Schwiening, Christof
AU - Killeen, Matthew J.
AU - Zhang, Yanhui
AU - Ma, Aiqun
AU - Lei, Ming
AU - Grace, Andrew A.
AU - Huang, Christopher L H
PY - 2009
Y1 - 2009
N2 - 1. Intracellular Ca2+ overload has been associated with established atrial arrhythmogenesis. The present experiments went on to correlate acute initiation of atrial arrhythmogenesis in Langendorff-perfused mouse hearts with changes in Ca2+ homeostasis in isolated atrial myocytes following pharmacological procedures that modified the storage or release of sarcoplasmic reticular (SR) Ca2+ or inhibited entry of extracellular Ca2+. 2. Caffeine (1 mmol/L) elicited diastolic Ca 2+ waves in regularly stimulated atrial myocytes immediately following addition. This was followed by a decline in the amplitude of the evoked transients and the disappearance of such diastolic events, suggesting partial SR Ca2+ depletion. 3. Cyclopiazonic acid (CPA; 0.15 μmol/L) produced more gradual reductions in evoked Ca2+ transients and abolished diastolic Ca2+ events produced by the further addition of caffeine. 4. Nifedipine (0.5 μmol/L) produced immediate reductions in evoked Ca2+ transients. Further addition of caffeine produced an immediate increase followed by a decline in the amplitude of the evoked Ca2+ transients, without eliciting diastolic Ca2+ events. 5. These findings correlated with changes in spontaneous and provoked atrial arrhythmogenecity in mouse isolated Langendorfperfused hearts. Thus, caffeine was pro-arrhythmogenic immediately following but not > 5 min after application and both C448ePA and nifedipine pretreatment inhibited such arrhythmogenesis. 6. Together, these findings relate acute atrial arrhythmogenesis in intact hearts to diastolic Ca2+ events in atrial myocytes that, in turn, depend upon a finite SR Ca2+ store and diastolic Ca2+ release following Ca2+-induced Ca 2+ release initiated by the entry of extracellular Ca2+. © 2009 Blackwell Publishing Asia Pty Ltd.
AB - 1. Intracellular Ca2+ overload has been associated with established atrial arrhythmogenesis. The present experiments went on to correlate acute initiation of atrial arrhythmogenesis in Langendorff-perfused mouse hearts with changes in Ca2+ homeostasis in isolated atrial myocytes following pharmacological procedures that modified the storage or release of sarcoplasmic reticular (SR) Ca2+ or inhibited entry of extracellular Ca2+. 2. Caffeine (1 mmol/L) elicited diastolic Ca 2+ waves in regularly stimulated atrial myocytes immediately following addition. This was followed by a decline in the amplitude of the evoked transients and the disappearance of such diastolic events, suggesting partial SR Ca2+ depletion. 3. Cyclopiazonic acid (CPA; 0.15 μmol/L) produced more gradual reductions in evoked Ca2+ transients and abolished diastolic Ca2+ events produced by the further addition of caffeine. 4. Nifedipine (0.5 μmol/L) produced immediate reductions in evoked Ca2+ transients. Further addition of caffeine produced an immediate increase followed by a decline in the amplitude of the evoked Ca2+ transients, without eliciting diastolic Ca2+ events. 5. These findings correlated with changes in spontaneous and provoked atrial arrhythmogenecity in mouse isolated Langendorfperfused hearts. Thus, caffeine was pro-arrhythmogenic immediately following but not > 5 min after application and both C448ePA and nifedipine pretreatment inhibited such arrhythmogenesis. 6. Together, these findings relate acute atrial arrhythmogenesis in intact hearts to diastolic Ca2+ events in atrial myocytes that, in turn, depend upon a finite SR Ca2+ store and diastolic Ca2+ release following Ca2+-induced Ca 2+ release initiated by the entry of extracellular Ca2+. © 2009 Blackwell Publishing Asia Pty Ltd.
KW - Atrial arrhythmogenesis
KW - Ca2+ homeostasis
KW - Murine hearts
U2 - 10.1111/j.1440-1681.2009.05170.x
DO - 10.1111/j.1440-1681.2009.05170.x
M3 - Article
SN - 0305-1870
VL - 36
SP - 969
EP - 980
JO - Clinical and Experimental Pharmacology and Physiology
JF - Clinical and Experimental Pharmacology and Physiology
IS - 10
ER -